Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline‐ and methoxamine‐evoked constriction of the dorsal hand vein
Open accessAbstract
Aims To examine whether the antidepressant venlafaxine, a novel serotonin‐noradrenaline re‐uptake inhibitor (SNRI), can modify α‐adrenoceptor‐mediated venoconstriction in man. The effects of venlafaxine were compared with those of desipramine, a tricyclic antidepressant with noradrenaline uptake inhibiting properties, and paroxetine, a selective serotonin re‐uptake inhibitor (SSRI), on noradrenaline‐and methoxamine‐evoked venoconstriction using the dorsal hand vein compliance technique. Methods Fifteen healthy male volunteers participated in five weekly experimental sessions. Each session was associated with a clinically effective dose of an antidepressant or placebo. The following oral dosages were used: venlafaxine 75 mg, venlafaxine 150 mg, desipramine 100 mg, paroxetine 20 mg, or placebo. A double‐blind, cross‐over, balanced design was used. In each session, dose–response curves to both locally infused noradrenaline acid tartrate (0.1–33.33 ng min−1 ) and methoxamine hydrochloride (0.5–121.5 μg min−1 ) were constructed. Systolic and diastolic blood pressure and pulse rate were measured in the supine and erect positions. Salivation was measured by the dental roll technique. Results Venlafaxine 150 mg and desipramine 100 mg potentiated the venoconstrictor response to noradrenaline (anova of log ED 50 s: P<0.01; individual comparisons: venlafaxine 150 mg vs placebo: P<0.005; mean difference, 95% CI: −0.49 (−0.81, −0.17); desipramine 100 mg vs placebo: P<0.005; mean difference, 95% CI: −0.34 (−0.60, −0.09) without affecting the response to methoxamine. Neither paroxetine nor placebo had any effects on the venoconstrictor responses. Both doses of venlafaxine increased systolic blood pressure (supine and erect) and venlafaxine 150 mg increased diastolic blood pressure (supine) (anova, P<0.05). Desipramine increased heart rate (P<0.05). Desipramine and both doses of venlafaxine reduced salivation (P<0.025). Conclusions These results show that, similarly to desipramine 100 mg, venlafaxine 150 mg can potentiate venoconstrictor responses to noradrenaline, consistent with venlafaxine’s ability to block noradrenaline uptake in man. The importance of noradrenaline uptake blockade in these observations is confirmed by the lack of effect of the antidepressants on methoxamine‐evoked venoconstriction and the failure of paroxetine to modify noradrenaline‐evoked venoconstriction.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The central accumulation of norepinephrine from SNRIs might have activated alpha-2 receptors and concurrent inhibition of parasympathetic salivary neurons in the brainstem, which lead to decreased salivary flow and dry mouth.
“The central accumulation of norepinephrine from SNRIs might have activated alpha-2 receptors and concurrent inhibition of parasympathetic salivary neurons in the brainstem, which lead to decreased salivary flow and dry mouth.3435”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Statistical estimations in enzyme kinetics
Wilkinson, G. (1961) · Biochemical Journal · doi:10.1042/bj0800324 · Cited by 3,566 · see citing works
Quantitative methods in psychology.
Lewis, D. (1960) · McGraw-Hill Book Company · doi:10.1037/11626-000 · Cited by 480 · see citing works
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
Watson, C. B., & Richelson, E. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90194-8 · Cited by 391 · see citing works
Muth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E. B. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90769-0 · Cited by 374 · see citing works
Binding of antidepressants to human brain receptors: focus on newer generation compounds
Cusack, B. M., Nelson, A. N., & Richelson, E. (1994) · Psychopharmacology · doi:10.1007/bf02244985 · Cited by 349 · see citing works
Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.
Richelson, E., & Nelson, A. N. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21446-x · Cited by 342 · see citing works
Preskorn, S. (1995) · PubMed · Cited by 327 · see citing works
Origin and organization of brainstem catecholamine innervation in the rat
Levitt, P., & Moore, R. Y. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901860402 · Cited by 327 · see citing works
A review of the metabolism and pharmacokinetics of paroxetine in man
Kaye, C. M., Haddock, R. E., Langley, P. F., MELLOWS, G., Tasker, T. C. G., Zussman, B. D., & Greb, W. H. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07176.x · Cited by 268 · see citing works
Pharmacology of Antidepressants—Characteristics of the Ideal Drug
Richelson, E. (1994) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61375-5 · Cited by 258 · see citing works
Muth, E. A., Moyer, J. A., Haskins, J. T., Andree, T. H., & Husbands, G. E. M. (1991) · Drug Development Research · doi:10.1002/ddr.430230210 · Cited by 212 · see citing works
Klamerus, K. J., Moloney, K., Rudolph, R. L., Sisenwine, S. F., Jusko, W. J., & Chiang, S. T. (1992) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1992.tb03875.x · Cited by 203 · see citing works
A new technique for recording compliance of human hand veins.
Aellig, W. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb00527.x · Cited by 162 · see citing works
The SHP Test—an Aid in the Detection and Measurement of Depression
Peck, R. E. (1959) · Archives of General Psychiatry · doi:10.1001/archpsyc.1959.03590010051006 · Cited by 154 · see citing works
TRENDELENBURG, U., Maxwell, R. A., & Pluchino, S. (1970) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28488-9 · Cited by 129 · see citing works
Antidepressant drug selection: criteria and options.
Preskorn, S. (1994) · PubMed · Cited by 115 · see citing works
Clinical Pharmacokinetics of Imipramine and Desipramine
Sallee, F. R., & Pollock, B. G. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018050-00002 · Cited by 114 · see citing works
Rapid cycling depression in adolescence
Spurkland, I., & Vandvik, I. H. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01300.x · Cited by 89 · see citing works
Alradi, A. O., & Carruthers, S. G. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.214 · Cited by 72 · see citing works
The human pharmacology of reboxetine
Szabadi, E., Bradshaw, C. M., Boston, P. F., & Langley, R. W. (1998) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199802)13:1+ · Cited by 32 · see citing works
Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans.
Vincent, J., Dachman, W. D., Blaschke, T. F., & Hoffman, B. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116050 · Cited by 31 · see citing works
A comparison of the effect of paroxetine and amitriptyline on the tyramine pressor response test.
Hassan, S., Wainscott, G., & Turner, P. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02700.x · Cited by 19 · see citing works
Haefeli, W. E., Srivastava, N., Kongpatanakul, S., Blaschke, T. F., & Hoffman, B. B. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.264.2.h364 · Cited by 19 · see citing works
Belz, G., Beermann, C., Schloos, J., & Kleinbloesem, C. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03550.x · Cited by 15 · see citing works
Pharmacotherapeutic profile of venlafaxine
Preskorn, S. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83307-x · Cited by 14 · see citing works
Spare alpha adrenoceptors in the peripheral circulation: excitation-contraction coupling.
Ruffolo, R. R. (1986) · PubMed · Cited by 14 · see citing works
Abdelmawla, A. H., Langley, R. W., Szabadi, E., & Bradshaw, C. M. (1995) · PubMed Central · Cited by 8 · see citing works
Schulte, K.-L., Laber, E., Braun, J., Meyer-Sabellek, W. A., Distler, A., & Gotzen, R. (1987) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(87)90074-7 · Cited by 7 · see citing works
Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension
Levenson, J. A., Simon, A. C., Moyse, D., Bouthier, J., & Safar, M. E. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90604-5 · Cited by 2 · see citing works
Cumulative and noncumulative dose-response curves to noradrenaline on the dorsal hand vein
Abdelmawla, A. H., Langley, R. W., Szabadi, E., & Bradshaw, C. M. (1996) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(96)00077-9 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- References effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins. Br J Clin Pharmacol 1989; 28: 1
- Szabadi E, Bradshaw CM, Boston PF, Langley RW. The J Pharmacol Exp Ther 1984; 230: 94-102.
- Hassan SM, Wainscott G, Turner P. A comparison of the 1979; 186: 505-528.
Cited by
Sorted by citations
Smith, D. D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I. M. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.5.396 · Cited by 537 · see citing works
Stahl, S. M., Grady, M. M., Moret, C., & Briley, M. (2005) · CNS Spectrums · doi:10.1017/s1092852900019726 · Cited by 462 · see citing works
Samuels, E., & Szabadi, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777193 · Cited by 454 · see citing works
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299 · see citing works
Wellington, K., & Perry, C. M. (2001) · CNS Drugs · doi:10.2165/00023210-200115080-00007 · Cited by 263 · see citing works
Deecher, D. C., & Dorries, K. M. (2007) · Archives of Women s Mental Health · doi:10.1007/s00737-007-0209-5 · Cited by 219 · see citing works
Oliva, V., Lippi, M., Paci, R., Del Fabro, L., Delvecchio, G., Brambilla, P., De Ronchi, D., Fanelli, G., & Serretti, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110266 · Cited by 219 · see citing works
Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions
Thase, M. E., Entsuah, R., Cantillon, M., & Kornstein, S. G. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.609 · Cited by 201 · see citing works
Allgulander, C., Hackett, D., & Salinas, E. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.1.15 · Cited by 175 · see citing works
Montgomery, S. A., Huusom, A. K. T., & Bothmer, J. (2004) · Neuropsychobiology · doi:10.1159/000078225 · Cited by 168 · see citing works
Differential physiological effects of a low dose and high doses of venlafaxine in major depression
Debonnel, G., Saint-André, É., Hébert, C., de Montigny, C., Lavoie, N., & Blier, P. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006413 · Cited by 148 · see citing works
Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases
Howell, C., Wilson, A. D., & Waring, W. S. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02849.x · Cited by 144 · see citing works
Cardiovascular Changes Associated With Venlafaxine in the Treatment of Late-Life Depression
Johnson, E. M., Whyte, E. M., Mulsant, B. H., Pollock, B. G., Weber, E., Begley, A. E., & Reynolds, C. F. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000204328.50105.b3 · Cited by 128 · see citing works
Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs
Freemantle, N., Anderson, I. M., & Young, P. J. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.4.292 · Cited by 107 · see citing works
What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause
Rossmanith, W. G., & Ruebberdt, W. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802632514 · Cited by 90 · see citing works
Elevated Risk of Preeclampsia in Pregnant Women With Depression: Depression or Antidepressants?
Palmsten, K. K., Setoguchi, S., Margulis, A. V., Patrick, A. R., & Hernández–Dı́az, S. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr394 · Cited by 90 · see citing works
Deecher, D. C. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.4.435 · Cited by 65 · see citing works
Escitalopram versus venlafaxine XR in the treatment of depression
Montgomery, S., & Andersen, H. F. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200609000-00008 · Cited by 60 · see citing works
Erectile and Ejaculatory Dysfunction Associated with Use of Psychotropic Drugs: A Systematic Review
Trinchieri, M., Trinchieri, M., Perletti, G., Magri, V., Stamatiou, K. N., Cai, T., Montanari, E., & Trinchieri, A. (2021) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2021.05.016 · Cited by 60 · see citing works
Deecher, D. C., Alfinito, P. D., Leventhal, L., Cosmi, S. A., Johnston, G. H., Merchenthaler, I. J., & Winneker, R. C. (2006) · Endocrinology · doi:10.1210/en.2006-1163 · Cited by 60 · see citing works
Sands, W. A., Martin, A. F., Strong, E. W., & Palmer, T. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001107 · Cited by 58 · see citing works
Cardiovascular adverse effects of newer antidepressants
Mago, R., Tripathi, N., & Andrade, C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.908709 · Cited by 54 · see citing works
Blier, P., Saint-André, É., Hébert, C., de Montigny, C., Lavoie, N., & Debonnel, G. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006395 · Cited by 54 · see citing works
Carminati, G. G., Deriaz, N., & Bertschy, G. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.10.002 · Cited by 52 · see citing works
Eker, S. S., Akkaya, C., Sarandöl, A., Cangür, Ş., Sarandöl, E., & Kırlı, S. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.12.029 · Cited by 51 · see citing works
Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy
Hanley, G. E., Smolina, K., Mintzes, B. J., Oberlander, T. F., & Morgan, S. G. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001200 · Cited by 50 · see citing works
Lazar, A., Walitza, S., Jetter, A., Gerlach, M., Warnke, A., Herpertz-Dahlmann, B., Gründemann, D., Grimberg, G., Schulz, E., Remschmidt, H., et al. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007742 · Cited by 51 · see citing works
Meta-analysis: Risk of dry mouth with second generation antidepressants
Cappetta, K., Beyer, C., Johnson, J. A., & Bloch, M. H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.012 · Cited by 49 · see citing works
The Effects of Venlafaxine on Autonomic Functions in Healthy Volunteers
Siepmann, T., Ziemssen, T., Müeck‐Weymann, M., Kirch, W., & Siepmann, M. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a255b · Cited by 47 · see citing works
The SNRI venlafaxine improves emotional unawareness in patients with post‐stroke depression
Cravello, L., Caltagirone, C., & Spalletta, G. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1021 · Cited by 37 · see citing works
Treatment of anxiety disorders with venlafaxine XR
Thase, M. E. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.3.269 · Cited by 36 · see citing works
Melichar, J., Haida, A., Rhodes, C. J., Reynolds, A. H., Nutt, D., & Malizia, A. L. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500102 · Cited by 28 · see citing works
Peritogiannis, V., Antoniou, K., Mouka, V., Mavreas, V. G., & Hyphantis, T. N. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089841 · Cited by 22 · see citing works
No Effect of a Selective Serotonergic/Noradrenergic Reuptake Inhibitor on Endurance Performance
Piacentini, M. F., MEEUSEN, R. R., Buyse, L., Schutter, G. D., & Meirleir, K. D. (2002) · European Journal of Sport Science · doi:10.1080/17461391.2002.10142578 · Cited by 22 · see citing works
Leong, C., Alessi‐Severini, S., Enns, M. W., Nie, Y., Sareen, J., Bolton, J. M., Prior, H. J., & Chateau, D. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000701 · Cited by 20 · see citing works
Ribback, S., Pavlovic, D., Herbst, D., Nedeljkov-Jancic, R., Wendt, M., Nedeljkov, V., Bleich, S., & Frieling, H. (2012) · PubMed · Cited by 20 · see citing works
Diaper, A., Rich, A. S., Wilson, S. J., Craig, K. J., Dourish, C. T., Dawson, G. R., Nutt, D., & Bailey, J. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2346 · Cited by 19 · see citing works
Hairi, H. A., Shuid, A. N., Ibrahim, N. ‘., Jamal, J. A., Mohamed, N., & Mohamed, I. N. (2017) · Current Drug Targets · doi:10.2174/1389450118666170816123740 · Cited by 17 · see citing works
van den Broek, W. W., Mulder, P., van Os, E., Birkenhäger, T., Pluijms, E. M., & Bruijn, J. A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089821 · Cited by 16 · see citing works
Akkaya, C., Sivrioglu, E. Y., Akgöz, S., Eker, S. S., & Kırlı, S. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.770 · Cited by 16 · see citing works
Scent of relief: Mastic resin scent recovers salivation in chronic dry mouth patients
Faruque, M. R. J., Potocka, W., Nazmi, K., Ligtenberg, A. J. M., Bikker, F. J., & Laine, M. L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117245 · Cited by 13 · see citing works
Balfour, J. A. B., & Jarvis, B. (2000) · CNS Drugs · doi:10.2165/00023210-200014060-00006 · Cited by 11 · see citing works
Yazicioglu, B., Akkaya, C., Sarandöl, A., Akgöz, S., Eker, S. S., & Kırlı, S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.018 · Cited by 11 · see citing works
Xi, Y., Bao, Z., Guo, Q., Wang, J., Jing, Z., Di, J., & Yang, K. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70176 · Cited by 10 · see citing works
Treatment-resistant Depression in Late Life
Flint, A. J. (2002) · CNS Spectrums · doi:10.1017/s1092852900008725 · Cited by 10 · see citing works
Lee, S., Song, Y. S., Kim, Y. N., & Ahn, E. (2018) · 대한구강보건학회지 · doi:10.11149/jkaoh.2018.42.2.46 · Cited by 9 · see citing works
Chugh, P. K., Kalra, B. S., Kaushik, N., & Tekur, U. (2013) · Europe PMC (PubMed Central) · Cited by 9 · see citing works
Xu, D., Zhu, H., & Wu, M. C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38561 · Cited by 8 · see citing works
Proctor, G. (2014) · Springer eBooks · doi:10.1007/978-3-642-55154-3_3 · Cited by 7 · see citing works
dos Santos, D. R., Fiais, G. A., Oliveira, H. A., Ribas, T. B., Souza, R. O., Tsosura, T. V. S., Matsushita, D. H., Ervolino, E., Dornelles, R. C. M., Nakamune, A. C. D. M. S., et al. (2022) · Clinical Oral Investigations · doi:10.1007/s00784-022-04539-1 · Cited by 6 · see citing works
Sassarini, J., Krishnadas, R., Cavanagh, J., Nicol, A., Pimlott, S. L., Ferrell, W. R., & Lumsden, M. A. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.12.003 · Cited by 5 · see citing works
Alev, L., Lenox‐Smith, A., Altın, M., & Dueñas, H. (2013) · Open Journal of Depression · doi:10.4236/ojd.2013.24011 · Cited by 5 · see citing works
Bupropion Switch for a Depressed Patient With Venlafaxine-Associated Night Sweats
Kavirajan, H. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000925 · Cited by 2 · see citing works
Akıncı, M., Karadağ, Ç. H., Hüseyın, S., Oltulu, Ç., Canbaz, S., Gündüz, Ö., & Topuz, R. D. (2019) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2018-0338 · Cited by 2 · see citing works
Neuroendokrinologie der Menopause: Wie entstehen Hitzewallungen?
Rossmanith, W. G., & Ruebberdt, W. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2 · see citing works
Dose optimisation in antidepressant drug development
Deakin, J. F. W. (2001) · International Congress Series · doi:10.1016/s0531-5131(01)00299-0 · Cited by 1 · see citing works
A Study of Dry Mouth and Gastrointestinal Disorders in Patients Taking Antidepressant
Heo, Y.-J., Yang, C.-M., Lee, H.-J., Lee, S.-Y., & Jang, S.-H. (2022) · Mood and Emotion · doi:10.35986/me.2022.20.1.15
- Authors
- Abdelmawla, Langley, Szabadi, & Bradshaw
- Affiliations
- Queen's Medical Centre (GB)
- Corresponding author
- Szabadi
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1999-09
- Volume
- 48
- Issue
- 3
- Pages
- 345-354
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- PMC
- PMC2014332
- OpenAlex
- W1542427252
- Cited by
- 58
- References
- 30
- Citations by year
- 2024: 3 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 1 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Clinical Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- venlafaxine, desipramine, paroxetine, antidepressants, venoconstriction, dorsal hand vein, norepinephrine, methoxamine, alpha-adrenergic receptors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, selective serotonin reuptake inhibitors, blood pressure, salivary secretion, dose-response relationship, venous compliance
- MeSH terms
- Venlafaxine Hydrochloride, Adrenergic alpha-Agonists, Adult, Blood Pressure, Cyclohexanols, Desipramine, Double-Blind Method, Drug Interactions, Hand, Heart Rate, Humans, Male, Methoxamine, Norepinephrine, Salivation, Vasoconstriction, Veins, Selective Serotonin Reuptake Inhibitors, Paroxetine, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review